이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

EBOS Group 관리

관리 기준 확인 3/4

EBOS Group's CEO는 John Cullity, Apr2018 에 임명되었습니다 의 임기는 6.42 년입니다. 총 연간 보상은 A$ 6.65M, 23.7% 로 구성됩니다. 23.7% 급여 및 76.3% 보너스(회사 주식 및 옵션 포함). 는 A$ 11.50M 가치에 해당하는 회사 주식의 0.18% 직접 소유합니다. 11.50M. 경영진과 이사회의 평균 재임 기간은 각각 4.8 년과 4.2 년입니다.

주요 정보

John Cullity

최고 경영자

AU$6.6m

총 보상

CEO 급여 비율	23.7%
CEO 임기	6.4yrs
CEO 소유권	0.2%
경영진 평균 재임 기간	5.6yrs
이사회 평균 재임 기간	4.2yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

John Cullity 의 보수는 EBOS Group 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	AU$7m	AU$2m	AU$272m
Mar 31 2024	n/a	n/a	AU$264m
Dec 31 2023	n/a	n/a	AU$257m
Sep 30 2023	n/a	n/a	AU$255m
Jun 30 2023	AU$8m	AU$2m	AU$253m
Mar 31 2023	n/a	n/a	AU$243m
Dec 31 2022	n/a	n/a	AU$233m
Sep 30 2022	n/a	n/a	AU$218m
Jun 30 2022	AU$6m	AU$1m	AU$203m
Mar 31 2022	n/a	n/a	AU$198m
Dec 31 2021	n/a	n/a	AU$194m
Sep 30 2021	n/a	n/a	AU$190m
Jun 30 2021	AU$4m	AU$1m	AU$185m
Mar 31 2021	n/a	n/a	AU$180m
Dec 31 2020	n/a	n/a	AU$174m
Sep 30 2020	n/a	n/a	AU$168m
Jun 30 2020	AU$4m	AU$1m	AU$163m
Mar 31 2020	n/a	n/a	AU$157m
Dec 31 2019	n/a	n/a	AU$152m
Sep 30 2019	n/a	n/a	AU$145m
Jun 30 2019	AU$2m	AU$1m	AU$138m
Mar 31 2019	n/a	n/a	AU$136m
Dec 31 2018	n/a	n/a	AU$134m
Sep 30 2018	n/a	n/a	AU$136m
Jun 30 2018	AU$1m	AU$287k	AU$137m

보상 대 시장: John 의 총 보상 ($USD 4.48M )은 Australian 시장( $USD 2.29M ).

보상과 수익: John 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

John Cullity

6.4yrs

테뉴어

AU$6,648,189

보상

Mr. John Cullity has been Non-Executive Director of Terry White Group Limited since March 29, 2018. Mr. Cullity has been Chief Executive Officer of EBOS Group Limited since April 1, 2018. Mr. Cullity serve...

리더십 팀

이름	위치	테뉴어	보상	소유권
John Cullity	Chief Executive Officer	6.4yrs	AU$6.65m	0.18% A$ 11.7m
Leonard Hansen	CFO & Chief Accountant	4.5yrs	데이터 없음	0.012% A$ 790.8k
Mithran Naiker	Chief Information Officer	no data	데이터 없음	데이터 없음
Janelle Cain	General Counsel	9.7yrs	데이터 없음	데이터 없음
Jacinta McCarthy	Group General Manager of Human Resources	4.8yrs	데이터 없음	데이터 없음
Simon Bunde	Executive General Manager of Strategic Operations	no data	데이터 없음	데이터 없음
Julie Dillon	Chief Executive Officer of Animal Care	2.8yrs	데이터 없음	데이터 없음
Brett Barons	Chief Executive Officer of Symbion	6.7yrs	데이터 없음	0.091% A$ 6.0m

5.6yrs

평균 재임 기간

경험이 풍부한 관리: EBO 의 관리팀은 노련하고 경험 (평균 재직 기간 5.6 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Mark Bloom	Independent Director	2yrs	AU$174.28k	데이터 없음
Elizabeth Coutts	Independent Chairman	21.2yrs	AU$373.02k	0.055% A$ 3.6m
Stuart McLauchlan	Independent Director	5.2yrs	AU$215.28k	0.0013% A$ 83.5k
Tracey Batten	Independent Director	3.2yrs	AU$176.92k	0.00077% A$ 50.2k
Julie Tay	Independent Director	1.3yrs	AU$161.10k	데이터 없음
Peter Williams	Independent Director	11.2yrs	AU$161.10k	데이터 없음

4.2yrs

평균 재임 기간

61.5yo

평균 연령

경험이 풍부한 이사회: EBO 의 이사회는 경험(평균 재직 기간 4.1 년)으로 간주됩니다.

EBOS Group 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

EBOS Group Limited Announces Chief Financial Officer Changes

Insider recently sold AU$4.9m worth of stock

EBOS Group Limited Announces the Appointment of Mark Bloom as an Independent Director, Effective 16 September 2022

Ebos Group Limited Announces Resignation of Nick Dowling as Director

Independent Director recently bought AU$55k worth of stock

EBOS Group Limited, Annual General Meeting, Oct 19, 2021

Recent updates

Final dividend of NZ$0.64 announced

EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

EBOS Group Limited Announces Chief Financial Officer Changes

Insider recently sold AU$4.9m worth of stock

First half dividend of NZ$0.60 announced

First half 2024 earnings released: EPS: AU$0.71 (vs AU$0.70 in 1H 2023)

EBOS Group Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

Now 20% undervalued

EBOS Group Limited to Report First Half, 2024 Results on Feb 21, 2024

EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million.

Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout Talk

EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross Pursuit

EBOS Not to Proceed with Acquisition in Animal Care Segment

EBOS Not to Proceed with Acquisition in Animal Care Segment

Now 21% undervalued

EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023

Now 21% undervalued

Upcoming dividend of NZ$0.60 per share at 3.0% yield

Ebos Group Limited Announces Dividend, Payable on 29 September 2023

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorates as stock falls 17%

Now 26% undervalued after recent price drop

First half 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

EBOS Group Limited to Report Q2, 2023 Results on Feb 22, 2023

EBOS Group Limited Announces the Appointment of Mark Bloom as an Independent Director, Effective 16 September 2022

Upcoming dividend of NZ$0.51 per share

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

EBOS Group Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 30 September, 2022

Upcoming dividend of NZ$0.49 per share

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Ebos Group Limited Announces Resignation of Nick Dowling as Director

Independent Director recently bought AU$55k worth of stock

Price target increased to AU$31.66

EBOS Group Limited Announces Supplementary Dividend for the Six Months Ended June 30, 2021, Payable on Sept. 24, 2021

Upcoming dividend of NZ$0.48 per share

EBOS Group Limited (EBOS) acquired Sentry Medical.

Full year 2021 earnings released: EPS AU$1.13 (vs AU$1.01 in FY 2020)

EBOS Group Limited (NZSE:EBO) acquired Pioneer Medical Limited for AUD 40 million.

Price target raised to AU$25.70

First half 2021 earnings released: EPS AU$0.57 (vs AU$0.51 in 1H 2020)

Revenue beats expectations

EBOS Group Limited (NZSE:EBO) acquired Vet Distribution Business of Clifford Hallam Healthcare Pty Ltd for AUD 9.2 million.

EBOS Group Limited (NZSE:EBO) acquired CH2 Vet for AUD 9.2 million.

EBOS Group Limited, Annual General Meeting, Oct 19, 2021

New 90-day high: AU$27.92

New 90-day high: AU$25.25

EBOS Group Limited (NZSE:EBO) entered into an agreement to acquire Cryomed Aesthetics Pty Limited for AUD 14.1 million.

New 90-day high: AU$23.26

New 90-day high - AU$21.38

Full year earnings released - EPS AU$1.01

New 90-day low - AU$20.00

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

이사회 구성원

평균 재임 기간

평균 연령